Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Appointed director
|
|
United Health Products, Inc. (UEEC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/31/2023 |
8-K
| Quarterly results |
| 09/07/2022 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 07/19/2022 |
8-K
| Quarterly results |
| 06/23/2022 |
8-K
| Quarterly results |
| 06/10/2022 |
8-K
| Quarterly results |
| 04/29/2022 |
8-K
| Quarterly results |
| 02/24/2022 |
8-K
| Quarterly results |
| 12/10/2021 |
8-K
| Quarterly results |
| 10/14/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data|
Docs:
|
"United Health Products Provides Business Update Henderson, Nevada – October 7, 2021 – United Health Products, Inc. , , developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, today provided an update on its regulatory approval application process and other business activities. As part of its substantive review process to evaluate UHP’s PMA application, the FDA has requested details on certain elements of the HemoStyp manufacturing process. In keeping with industry best practices, UHP recently completed the implementation of an industry standard Good Manufacturing Practices software tool and will be submitting a response to the FDA’s request later this month. Separately, UHP’s registration statement was declared effect...",
"Investor Presentation" |
|
| 06/28/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits |
| 05/05/2021 |
8-K
| Quarterly results |
| 01/11/2021 |
8-K
| Quarterly results |
| 05/22/2020 |
8-K/A
| Other Events |
| 05/14/2020 |
8-K
| Quarterly results |
| 04/08/2020 |
8-K
| Other Events |
| 04/02/2020 |
8-K/A
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State... |
| 03/30/2020 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial State... |
| 12/23/2019 |
8-K
| Quarterly results |
| 10/09/2019 |
8-K
| Quarterly results |
| 09/06/2019 |
8-K
| Other Events |
| 10/01/2018 |
8-K
| Quarterly results |
| 07/26/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/02/2018 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits |
| 03/19/2018 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/05/2017 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/06/2017 |
8-K
| Quarterly results |
| 08/19/2016 |
8-K
| Form 8-K - Current report |
| 08/10/2015 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
| 07/16/2015 |
8-K
| Other Events |
| 06/26/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/20/2015 |
8-K/A
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 01/16/2015 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 11/13/2014 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office... |
| 10/21/2014 |
8-K
| Other Events |
|
|
|